ThinkstockWellPoint Inc. (NYSE: WLP) and Tenet Healthcare Inc. (NYSE: THC) both reported third-quarter 2012 earnings this morning. WellPoint is health care benefits company and Tenet is a hospital operator. For the quarter, WellPoint posted…
Wikimedia CommonsPfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration approved its drug candidate called XELJANZ. The treatment here is for rheumatoid arthritis and this is the 5 mg twice…
via Wikimedia CommonsBioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is surging on news that a drug met its primary endpoint and that it will seek approval in early 2013. The company’s Phase III study of GALNS is for the treatment…
ThinkstockWalgreen Co. (NYSE: WAG) is still trying to recover from weak comparable store sales figures. The drug store giant reported that October same-store sales were down by 5.9%, worse than expected, due to changes…
ThinkstockHumana Inc. (NYSE: HUM) said this morning that its third-quarter net income fell 4.3% but it lifted its earnings outlook for the full year. The health care company also announced a pair of deals…
Wikimedia CommonsPfizer Inc. (NYSE: PFE) is out with its earnings report for the third quarter, and the drug giant reported that revenues were down 16% to $14.0 billion. Some 12% was due to an…
DaVita Inc. (NYSE: DVA) has been running very well and it was no mystery as to why Warren Buffett’s new portfolio managers have continued accumulating shares on behalf of Berkshire Hathaway Inc. (NYSE: BRK-A).…
via Wikimedia CommonsThere is some potentially very good news for those with gastrointestinal stromal tumors. The FDA has granted a priority review to the New Drug Application of Bayer HealthCare and Onyx Pharmaceuticals, Inc.…
Merck & Co. (NYSE: MRK) this morning reported better-than-expected third-quarter earnings, but the loss of market exclusivity for its Singulair in the United States and the impact of foreign exchange took a toll on…
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec Inc. (NASDAQ:…
Eli Lilly (NYSE: LLY) this morning reported disappointing third-quarter results as generic drugs took a toll on its sales. The Indianapolis-based drug maker posted adjusted earnings per share (EPS) of $0.79 on revenues of…
BSD Medical Corp. (NASDAQ: BSDM) is seeing its shares surge on positive news about tumors in rectal cancer. The company announced that published study results demonstrated improved rates of complete pathological tumor response in…
Pfizer Inc. (NYSE: PFE) said today that it will acquire privately held NextWave Pharmaceuticals. NextWave is a specialty pharmaceutical company that focuses on the development and commercialization of products for the treatment of attention…
WebMD Health Corp. (NASDAQ: WBMD) said that on Thursday its board of directors has signed off an amendment to its shareholder rights agreement to guard against coercive takeovers and other tactics that might be…
The U.S. is currently facing a severe shortage of doctors. The Association of American Medical Colleges predicts that by 2020, the shortage will amount to more than 90,000 doctors, including 45,000 patient care physicians.…